Abstract
In this review article, the clinical and histopathological characteristics of oral premalignant lesions, and primarily oral leukoplakia, are noted and the risk factors for malignant transformation of oral leukoplakia are discussed. Malignant transformation rates of oral leukoplakia range from 0.13 to 17.5%. The risk factors of malignant transformation in the buccal mucosa and labial commissure are male gender with chewing tobacco or smoking in some countries such as India, or older age and/or being a non-smoking female in other countries. Some authors have reported that leukoplakia on the tongue or the floor of the mouth showed a high risk of malignant transformation, although others have found no oral subsites at high risk. In concurrence with some authors, the authors of this review view epithelial dysplasia as an important risk factor in malignant transformation; however, there are conflicting reports in the literature. Many authors believe that nonhomogeneous leukoplakia is a high risk factor without exception, although different terms have been used to describe those conditions. The large size of lesions and widespread leukoplakia are also reported risk factors. According to some studies, surgical treatment decreased the rate of malignant transformation; however, many review articles state that no definitive treatment including surgery can decrease the malignant transformation rate of oral leukoplakia because of the lack of randomized control trials of treatment. Tobacco chewing and smoking may be causative agents for cancerization of oral leukoplakia in some groups, and evidence for a role of human papilloma virus in the malignant transformation of oral leukoplakia is inconsistent. Further research to clarify its role in malignant transformation is warranted.
Similar content being viewed by others
References
Kramer IRH, Lucas RB, Pindborg JJ et al (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518–539
World Health Organization (1973) Report from a meeting of investigation on histological definition of precancerous lesions. CAN/731, Geneva
Axell T, Pindborg JJ, Smith CJ et al (1996) Oral white lesions with special reference to precancerous and tobacco-related lesions. J Oral Pathol Med 25:49–54
Pindborg JJ, Reichart PA, Smith CJ et al (1997) World Health Organization: Histological typing of cancer and precancer of the oral mucosa, 2nd edn. Springer, Berlin
Warnakulasuriya S, Johnson NW, van der Wall I (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36:575–580
Einhorn J, Wersall J (1967) Incidence of oral carcinoma in patients with leukoplakia of oral mucosa. Cancer (Phila) 20:2189–2193
Roed-Petersen B (1971) Cancer development in oral leukoplakia follow-up of 331 patients. J Dent Res 50:711
Silverman S Jr, Bhargava K, Mani NJ et al (1976) Malignant transformation and natural history of oral leukoplakia in 57518 industrial workers of Gujarat, India. Cancer (Phila) 38:1790–1795
Banoczy J, Sugar L (1972) Longitudinal studies in oral leukoplakias. J Oral Pathol 1:265–272
Gupta PC, Mehta FS, Daftary DR et al (1980) Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10 year follow-up study of Indian villagers. Community Dent Oral Epidemiol 8:287–333
Baric JM, Alman JE, Feldman RS et al (1982) Influence of cigarette, pipe, and cigar smoking, removable partial dentures, and age on oral leukoplakia. Oral Surg Oral Med Oral Pathol 54:424–429
Pindborg JJ, Jølst O, Renstrup G et al (1968) Studies in oral leukoplakia. A preliminary report on the period prevalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients. J Am Dent Assoc 76:767–771
Waldron CA, Shafer WG (1975) Leukoplakia revisited: a clinicopathologic study of 3256 oral leukoplakias. Cancer (Phila) 36:1386–1392
Silverman S Jr, Gorsky M, Lozada F (1984) Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer (Phila) 53:563–568
Schepman KP, van der Meij EH, Smeele LE et al (1998) Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 34:270–275
Cowan CG, Gregg TA, Napier SS et al (2001) Potentially malignant oral lesions in northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis 7:18–24
Saito T, Sugiura C, Hirai A et al (2001) Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 30:49–53
Amagasa T, Yamashiro M, Ishikawa H (2006) Oral leukoplakia related to malignant transformation. Oral Sci Int 3:45–55
Mehta FS, Pindborg JJ, Gupta PC et al (1969) Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer (Phila) 24:832–849
Gupta PC (1989) Leukoplakia and incidence of oral cancer. J Oral Pathol Med 18:17
Roed-Petersen B, Renstrup G (1969) A topographical classification of oral mucosa suitable for electronic data processing its application to 560 leukoplakias. Acta Odont Scand 27:681–695
Napier SS, Speight PM (2008) Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 37:1–10
Nagao T, Ikeda N, Fukano H et al (2005) Incidence rates for oral leukoplakia and lichen planus in a Japanese population. J Oral Pathol Med 34:532–539
Kirita T, Horiuchi K, Tsuyuki M et al (1995) Clinico-pathological study on oral leukoplakia: evaluation of potential for malignant transformation. Jpn J Oral Maxillofac Surg 41:26–35
Pindborg JJ, Renstrup G, Poulsen HE et al (1963) Studies in oral leukoplakias. V. Clinical and histologic signs of malignancy. Acta Odont Scand 21:407–414
van der Waal I, Schepman KP, van der Meiji EH et al (1997) Oral leukoplakia: a clinicopathological review. Oral Oncol 33:291–301
Hansen LS, Olson JA, Silverman S Jr (1985) Proliferative verrucous leukoplakia: a long-term study of thirty patients. Oral Surg Oral Med Oral Pathol 60:285–298
Shear M, Pindborg JJ (1980) Verrucous hyperplasia of the oral mucosa. Cancer (Phila) 46:1855–1962
Sugár L, Bánóczy J (1969) Follow-up studies in oral leukoplakia. Bull WHO 41:289–293
Amagasa T, Michi K, Saito K et al (1977) Clinical classification of oral leukoplakia (in Japanese). Jpn J Oral Maxillofac Surg 23:89–96
Dawsey SM, Fleischer DE, Wang GQ et al (1998) Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer (Phila) 83:220–231
Freitag CP, Barros SG, Kruel CD et al (1999) Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern Brazil. Dis Esophagus 12:191–195
Nakanishi Y, Ochiai A, Yoshimura K (1998) The clinicopathologic significance of small areas unstained by Lugol’s iodine in the mucosa surrounding resected esophageal carcinoma. Cancer (Phila) 82:1454–1459
Shimizu Y, Tsukagoshi H, Fujita M et al (2001) Endoscopic screening for early esophageal cancer by iodine staining in patients with other current or prior primary cancers. Gastrointest Endsc 53:1–5
Maeda K, Suzuki T, Ohyama Y et al (2009) Colorimetric analysis of unstained lesions surrounding oral squamous cell carcinomas and oral potentially malignant disorders using iodine. Int J Oral Maxillofac Surg 39:486–492
Maeda K, Yamashiro M, Michi Y et al (2009) Effective staining method with iodine for leukoplakia and lesions surrounding squamous cell carcinoma of the tongue assessed by colorimetric analysis. J Med Dent Sci 56:123–130
Mehta FS, Shroff BC, Gupta PC et al (1972) Oral leukoplakia in relation to tobacco habits: a ten-year follow-up study of Bombay policeman. Oral Surg Oral Med Oral Pathol 34:426–433
Kramer IRH (1969) Precancerous conditions of oral mucosa. A computer-aided study. Ann R Coll Surg Engl 45:340–356
Silverman S Jr, Rozen RD (1968) Observations on the clinical characteristics and natural history of oral leukoplakia. J Am Dent Assoc 76:772–777
Banoczy J (1977) Follow-up studies in oral leukoplakia. J Maxillofac Surg 5:69–75
Lind PO (1987) Malignant transformation in oral leukoplakia. Scand J Dent Res 95:449–455
Gangadharan P, Paymaster JC (1971) Leukoplakia: an epidemiologic study of 1504 cases observed at the Tata Memorial Hospital, Bombay, India. Br J Cancer 25:657–668
Lan AX, Guan XB, Sun Z (2009) Analysis of risk factors for carcinogenesis of oral leukoplakia. Zhonghua Kou Qiang Yi Xue Za Zhi 44:327–331
Chiesa F, Boracchi P, Tradati N et al (1993) Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Oral Oncol Eur J Cancer 29B:23–28
Kramer IRH, El-Labban N, Lee KW (1978) The clinical features and risk of malignant transformation in sublingual keratosis. Br Dent J 144:171–180
Pogrel MA (1979) Sublingual keratosis and malignant transformation. J Oral Pathol 8:176–178
Inoue A, Sakamoto A, Uchida M et al (1985) Malignant progression of oral leukoplakia. J Jpn Soc Cancer Ther 20:18–24
Lumerman H, Freedman P, Kerpel S (1995) Oral epithelial dysplasia and the development of invasive squamous carcinoma. Oral Surg Oral Med Oral Pathol 79:321–329
Mehta FS, Gupta PC, Pindborg JJ (1981) Chewing and smoking habits in relation to precancer and oral cancer. J Cancer Res Clin Oncol 99:35–39
Gupta PC, Bhonsle RB, Murti PR et al (1989) An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer (Phila) 63:2247–2252
Holmstrup P, Vedtofte P, Reibel J et al (2006) Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42:461–474
Saito T, Sugiura A, Notani K et al (1999) High malignant transformation rate of widespread multiple oral leukoplakias. Oral Dis 5:15–19
Mincer HH, Coleman SA, Hopkins KP (1972) Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol 33:389–399
Bánóczy J, Csiba Á (1976) Occurrence of epithelial dysplasia in oral leukoplakia: analysis and follow-up study of 120 cases. Oral Surg Oral Med Oral Pathol 42:766–774
Pindborg JJ, Daftary DK, Mehta FS (1977) A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol 43:383–390
Pindborg JJ, Reibel J, Holmstrup P (1985) Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 14:698–708
Abbey L, Kaugars GE, Gunsolley JC et al (1995) Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol 80:188–191
Karabulut A, Reibel J, Therkildsen MH et al (1995) Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 24:198–200
van der Waal I (2009) Potentially malignant disorders of the oral and oropharyngeal mucosa: terminology, classification and present concepts of management. Oral Oncol 45:317–323
Vedtofte P, Holmstrup P, Hjorting-Hansen E et al (1987) Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg 16:656–664
Schoelch ML, Sekandari N, Regezi JA et al (1999) Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 109:949–953
Lodi G, Sardella A, Bez C et al (2006) Interventions for treating oral leukoplakia. Cochrane Database Syst Rev; CD001829
Lodi G, Porter S (2008) Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med 37(2):63–69
Zhang L, Poh CF, Lam WL et al (2001) Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection. Oral Oncol 37:505–512
Roodenburg JL, Panders AK, Vermey A (1991) Carbon dioxide laser surgery of oral leukoplakia. Oral Surg Oral Med Oral Pathol 71:670–674
Ishii J, Fujita K, Munemoto S et al (2004) Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features. J Clin Laser Med Surg 22:27–33
Browne RM, Potts AJC (1986) Dysplasia in salivary gland ducts in sublingual leukoplakia and erythroplakia. Oral Oncol 62:44–49
Hays GL, Lippman SM, Flaitz CM et al (1995) Co-carcinogenesis and field cancerization: oral lesions offer first signs. J Am Dent Assoc 126:47–51
Scholes AG, Woolgar JA, Boyle MA et al (1998) Synchronous oral carcinomas: independent or common clonal origin? Cancer Res 58:2003–2006
Lele S (2005) Although leukoplakia responds to some treatments relapses and adverse effects are common. Evid Based Dent 6:15–16
Lodi G, Sardella A, Bez C et al (2002) Systematic review of randomized trials for the treatment of oral leukoplakia. J Dent Educ 66:896–902
Epstein JB, Gorsky M (1999) Topical application of vitamin A to oral leukoplakia: a clinical case series. Cancer (Phila) 86:921–927
Epstein JB, Gorsky M, Wong FLW et al (1998) Topical bleomycin for the treatment of dysplastic oral leukoplakia. Cancer (Phila) 83:629–634
Shiu MN, Chen THH, Chang SH et al (2000) Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 82:1871–1874
Yen AM, Chen SC, Chang SH et al (2008) The effect of betel quid and cigarette on multistate progression of oral pre-malignancy. J Oral Pathol Med 37(7):417–422
Miller CS, White DK (1996) Human papillomavirus expression in oral mucosa, premalignant conditions and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82:57–68
Campisi G, Giovannelli L, Ammatuna P et al (2004) Proliferative verrucous vs. conventional leukoplakia: no significantly increased risk of HPV infection. Oral Oncol 40:835–840
Palefsky JM, Silverman S Jr, Abdel-Salaam M et al (1995) Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med 24:193–197
Bouda M, Gorgoulis VG, Kastrinakis NG et al (2000) High risk HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal mucosa. Mod Pathol 13:644–653
Gillison L, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:721–728
Miller CS, Johnstone BM (2001) Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:622–635
Chang KC, Su IJ, Tsai ST et al (2002) Pathological features of betel quid-related oral epithelial lesions in Taiwan with special emphasis on the tumor progression and human papillomavirus association. Oncology 63:362–369
Szarka K, Tar I, Fehér E et al (2009) Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential. Oral Microbiol Immunol 24(4):314–318
Campisi G, Panzarella V, Giuliani M et al (2007) human papillomavirus: its identikit and controversial role in oral oncogenesis, premalignant and malignant lesions. Int J Oncol 30:813–823 (Review)
Fouret P, Martin F, Flahault A et al (1995) Human papillomavirus infection in malignant and premalignant head and neck epithelium. Diagn Mol Pathol 4:122–127
Gassenmaier A (1988) Papilloma virus DNA (HPV) in leukoplakia and cancerous alterations of the oral mucosa. Dtsch Z Mund Kiefer Gesichtschir 12:149–151
Gassenmaier A, Hornstein OP (1988) Presence of human papilloma-virus DNA in benign and precancerous oral leukoplakia and squamous cell carcinomas. Dermatologica 176:224–233
Perrons C, Brink N, Jalal H et al (2005) The impact of high risk human papillomavirus testing an inner London colposcopy clinic. J Med Virol 76:576–582
Lee SY, Cho NH, Choi EC et al (2010) Relevance of human papilloma virus (HPV) infection to carcinogenesis of oral tongue cancer. Int J Oral Maxillofac Surg 39:678–683
Yang SW, Lee YS et al (2009) Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation. Cancer Epidemiol 33(2):118–122
Acay R, Rezende N et al (2008) Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification. Oral Microbiol Immunol 23(4):271–274
Conflict of interest
No author has any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Amagasa, T., Yamashiro, M. & Uzawa, N. Oral premalignant lesions: from a clinical perspective. Int J Clin Oncol 16, 5–14 (2011). https://doi.org/10.1007/s10147-010-0157-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-010-0157-3